ARTICLE / CLIENT ALERT
Federal Court of Justice Tightens Data Room Disclosure Requirements for Sellers, M&A Advisors and Other Parties
September 20, 2023
Read time: 9 min
I. Usual exclusion of liability for facts disclosed in the data room
In corporate acquisitions, the following market standard has become established for limiting the seller’s liability: A seller’s liability for a breach of a contractual warranty is excluded if the facts were disclosed to the buyer in advance, usually during due diligence. Disclosed” is regularly deemed to be at least the content of an electronic data room in which the seller posts documents and information about the object of purchase and thus makes them available to the prospective buyer for review. For evidentiary purposes, the contents of the data room are saved on a data carrier and frequently handed over to a notary for safekeeping.
Electronic data rooms typically contain a wealth of documents and information from different stages of a transaction and from different areas of due diligence (financial, commercial, legal, tax, etc.). The content of the data room usually consists of documents pre-selected by the seller and supplementary documents requested by the buyer during the due diligence process. Data rooms are structured and organized in different ways. In the course of contract negotiations, the question is regularly discussed as to whether further requirements should be placed on the manner of disclosure in the data room before such disclosure exposes the seller to liability. In practice, various standards have developed under the heading “Fairly Disclosed” which are intended to specify the seller’s disclosure obligations and ensure that documents and information are made available by the seller in such a way that a buyer can also become aware of them. In this respect, increased requirements are regularly placed on the (folder) structure, the correct classification of documents within the structure and the content of the documents.
II. Judgment of the Federal Court of Justice
In a Federal Court of Justice judgment dated September 15 (V ZR 77/22), the 5th Civil Senate com-mented on a real estate seller’s disclosure obligations when setting up a data room. In this case, three days before the notarization of the purchase agreement, the seller posted in the data room minutes of an owners’ meeting that had taken place more than two years ago. The minutes indi-cated a risk of a possible loss that could exceed the purchase price many times over. The seller had not separately drawn the buyer’s attention to the provision of this document and had not expressly excluded this risk from the agreed catalog of warranties in the purchase agreement signed shortly thereafter.
In accordance with the principle of “fair disclosure”, which is widespread in practice, the Court con-siders the disclosure obligations of a seller to be fulfilled only “if and to the extent that he can have the legitimate expectation on the basis of the circumstances that the buyer will become aware of the fact subject to disclosure by inspecting the data room”. The manner of disclosure must be such that “the purchaser will specifically review the records not merely for the purpose of general in-formation, but from a particular point of view”. In the opinion of the Court, a simple record of an owners’ meeting without further reference is not sufficient to adequately inform a purchaser of a possible risk that may significantly exceed the purchase price. For sufficient disclosure of such facts, the Court considers expert opinions or documents of similar quality to be necessary instead. The Court also lets it be known that the timing of the disclosure—shortly before the notarization date—also places an increased duty of disclosure on the seller.
However, the Court cited another aspect in its ruling that will be equally important. This is not a question of how disclosure is to be made, but rather which specific facts are to be disclosed. It is almost impossible for a buyer looking at the target company from the outside to conclusively identi-fy the relevant risks and request any missing documents from the seller. Here, a buyer is regularly dependent on the careful and dutiful cooperation of the seller. In the contract negotiations, the parties consistently struggle to obtain a guarantee from the seller that the buyer has been provided with “all information relevant to the transaction”. In the present case, due to the importance of the facts to be disclosed, the Court recognized that the seller also had to inform the buyer about the relevant facts “without being asked”. The Court was not even concerned with a corresponding guarantee in the purchase contract.
III. Outlook
Moving forward, sellers, M&A advisors and others involved in the organization of a data room on the seller’s side will have to observe heightened duties of care when selecting, setting up and sup-porting the data room.
In particular, the parties should observe the following points in the future:
• Selection of professional data rooms: The parties should select a professional data room provided by an appropriate service provider. Professional data rooms offer necessary func-tions for an appropriate structure and organization. Authorized persons are automatically notified of the upload of new documents by email.
• Disclosure shortly before the transaction is completed: More stringent requirements may be placed on disclosures shortly before the transaction is completed. In practice, this will play a role in disclosures after the completion of due diligence and shortly before the sign-ing of the contract. Here, an automatically generated notification from the data room pro-vider about new documents in the data room might not be sufficient, especially if it relates to relevant facts and the seller have given a credible assurance in advance that such facts are not applicable to the target company.
• Selection of documents to be disclosed: In particular, facts that represent a material poten-tial risk for the target company should be disclosed “unsolicited” by the seller.
• Type and manner of disclosure (concretization of “fair disclosure”): When selecting docu-ments, care must be taken to ensure that material risks are not disclosed as “hidden” but “present”.
II. Urteil des Bundesgerichtshofs vom 15. September 2023
In einem Urteil des Bundesgerichtshofs vom 15. September (V ZR 77/22) hat sich jetzt der 5. Zivilsenat zu den Aufklärungspflichten eines Immobilienverkäufers bei Einrichtung eines Datenraums geäußert. Das Urteil des Gerichts wird auch für den M&A Markt eine große Relevanz entfalten. In dem vom Bundesgerichtshof entschiedenen Fall hat der Verkäufer drei Tage vor der Beurkundung des Kaufvertrags im Datenraum ein Protokoll einer bereits über zwei Jahre zurückliegenden Eigentümerversammlung eingestellt, aus dem sich das Risiko eines möglichen Schadens, der den Kaufpreis um ein Vielfaches übersteigen könnte, erkennen ließ. Auf die Bereitstellung dieses Dokuments hatte der Verkäufer den Käufer nicht gesondert aufmerksam gemacht und dieses Risiko auch nicht im kurz darauf unterzeichneten Kaufvertrag ausdrücklich vom vereinbarten Garantiekatalog ausgenommen.
Entsprechend dem in der Praxis weit verbreiteten Grundsatz des „Fair Disclosure“ sieht das Gericht in seiner Urteilsbegründung die Aufklärungspflichten eines Verkäufers nur dann als erfüllt an, „wenn und soweit er aufgrund der Umstände die berechtigte Erwartung haben kann, dass der Käufer durch die Einsichtnahme in den Datenraum Kenntnis von dem offenbarungspflichtigen Umstand erlangen wird“. Die Art und Weise der Offenlegung muss derart erfolgen, dass „der Käufer die Unterlagen nicht nur zum Zweck allgemeiner Information, sondern unter einem bestimmten Gesichtspunkt gezielt durchsehen wird“. Ein schlichtes Protokoll einer Eigentümerversammlung ist ohne weiteren Hinweis nach Ansicht des Bundesgerichtshofs nicht ausreichend, um einen Käufer adäquat über ein mögliches Risiko aufzuklären, das den Kaufpreis ggf. deutlich übersteigen kann. Für eine ausreichende Offenlegung solcher Sachverhalte hält das Gericht stattdessen Gutachten oder Dokumente ähnlicher Qualität für erforderlich. Der Bundesgerichtshof lässt zudem durchklingen, dass auch der Zeitpunkt der Offenlegung – kurz vor dem Beurkundungstermin – eine erhöhte Aufklarungspflicht an den Verkäufer stellt.
Der Bundesgerichtshof führt in seiner Urteilsbegründung allerdings einen weiteren Aspekt an, der für die Praxis ebenso von großer Bedeutung sein wird. Hierbei geht es nicht um die Frage, wie offenzulegen ist, sondern welche konkreten Sachverhalte offenzulegen sind. Einem von extern auf das Zielunternehmen blickenden Käufer ist es nahezu unmöglich, die relevanten Risiken abschließend zu identifizieren und etwaige fehlende Dokumente beim Verkäufer anzufragen. Hier ist ein Käufer regelmäßig auf die sorgfältige und pflichtbewusste Mitwirkung des Verkäufers angewiesen. In den Vertragsverhandlungen ringen die Parteien regelmäßig um eine Garantie durch den Verkäufer, dass dem Käufer „alle für die Transaktion relevanten Informationen“ zur Verfügung gestellt wurden. Im vorliegenden Fall hat das Gericht aufgrund der Bedeutung des offenzulegenden Sachverhalts darauf erkannt, dass der Verkäufer auch „ungefragt“ den Käufer über den relevanten Sachverhalt aufzuklären hatte. Auf eine entsprechende Garantie im Kaufvertrag kam es dem Gericht gar nicht an.
III. Ausblick
Die Auswirkungen des Urteils auf die M&A Praxis werden mit Spannung zu beobachten sein. In jedem Fall werden Verkäufer, M&A Berater und weitere auf Verkäuferseite in die Organisation eines Datenraums eingebundene Berater bei der Auswahl, dem Aufbau und der Betreuung des Datenraums erhöhte Sorgfaltspflichten zu beachten haben.
Insbesondere auf folgende Punkte gilt es künftig zu achten:
• Auswahl professioneller Datenräume: Es sollte ein professioneller Datenraum, der von einem entsprechenden Dienstleister zur Verfügung gestellt wird, ausgewählt werden. Professionelle Datenräume bieten erforderliche Funktionen für eine angemessene Struktur und Organisation. Insbesondere werden Berechtigte automatisch über den Upload neuer Dokumente per E-Mail informiert.
• Offenlegung kurz vor Abschluss der Transaktion: An eine Offenlegung kurz vor Abschluss der Transaktion können noch einmal erhöhte Anforderungen zu stellen sein. In der Praxis wird das vor allem bei Offenlegungen nach Abschluss der Due Diligence und kurz vor Vertragsunterzeichnung eine Rolle spielen. Hier könnte eine bloße automatisch generierte Mitteilung des Datenraumanbieters über neue Dokumente im Datenraum nicht ausreichen, insbesondere wenn sie sich auf Sachverhalte von hoher Relevanz bezieht und die Käufer vorab glaubhaft versichert haben, dass solche Sachverhalte für das Zielunternehmen nicht zutreffend sind.
• Auswahl der offenzulegenden Dokumente: Insbesondere Sachverhalte, die ein wesentliches mögliches Risiko für das Zielunternehmen darstellen, sind auch „ungefragt“ durch den Verkäufer offenzulegen.
• Art und Weise der Offenlegung (Konkretisierung des „Fair Disclosure“): Bei der Auswahl der Dokumente ist darauf zu achten, dass insbesondere wesentliche Risiken nicht als „versteckt“ sondern „präsent“ offengelegt werden.

HPE Europe 2023 | Key Takeaways
ARTICLE
HPE Europe 2023 | Key Takeaways
September 21, 2023
Read time: 5 min
240+ leading individuals in healthcare, life sciences and private equity gathered at The Langham Hotel in central London for HPE Europe 2023 for a day packed with fireside chats, in-depth plenary sessions and an abundance of networking opportunities. We’ve distilled the key findings around investment trends, market challenges, innovative advancements, financing dynamics and forecasts for 2024.
INVESTING IN THE FUTURE OF HEALTHCARE
Healthcare private equity professionals remain bullish about the outlook for transactions going forward, despite a slow year for deals. We have seen more and more specialist investors emerging in Europe over the past decade and institutional investors are increasingly keen to back managers that recognise that healthcare is heterogenous and its many sub-sectors all come with their own complexities, headwinds and drivers.
- We are entering a golden age of innovation in healthcare, with many new drugs being discovered and advances in cell and gene therapies building on significant learnings gained during the pandemic. Further, the fast-moving integration between drug development and diagnostics is contributing to a major step-change in how things are being done.
- Some of the sub-sectors that are currently in focus for healthcare investors in Europe include pharma services, medtech, personalized medicine, generics and specialty pharma, with a particular appetite for assets embracing the use of data science and artificial intelligence.
- The tide is turning for healthcare deals, with opportunities being created in Europe by regulatory and political change, technology adoption that is now more tangible than ever, and the need to address pinch points in value chains.
CLOSING DEALS IN THE CURRENT MARKET
Despite strong views on the medium to longer term, much of the discussion at HPE Europe centred around the challenges that currently stand in the way of deals getting done, and how those might be overcome.
- After a challenging period for dealmakers, we are now seeing a bifurcation of deal activity. There is a big disparity in appetite between Tier A and Tier B assets, with the financing and demand there for premium companies but not necessarily for others.
- The tight M&A environment and depressed public markets are driving innovation in deal structures, with more take-privates, club deals, minority deals and continuation funds. We expect these themes to continue as the deal landscape improves, with further use of structuring to close the gap between buyer and seller pricing expectations.
- Value creation strategies focused on embracing technology to drive efficiencies and geographic expansion to diversify risk across markets are a focus for investors. When it comes to exits, there is a shift in the buyer landscape in favour of strategics.
CHALLENGES AND OPPORTUNITIES IN THE FINANCING MARKETS
Another big focus for healthcare investors today is clearly the changing dynamics in the financing markets, where the era of cheap debt is undoubtedly over and access to finance providers is much more limited than it is has been in recent years. Panellists felt the uncertainty was highlighting the paramount importance of strong relationships with lenders, who themselves are now much more focused on risk than they are on absolute returns.
- Challenges and Opportunities in the Financing Markets
- Another big focus for healthcare investors today is clearly the changing dynamics in the financing markets, where the era of cheap debt is undoubtedly over and access to finance providers is much more limited than it is has been in recent years. Panellists felt the uncertainty was highlighting the paramount importance of strong relationships with lenders, who themselves are now much more focused on risk than they are on absolute returns.
PREDICTIONS FOR 2024
Many of the speakers and delegates present at HPE Europe were asked to look into their crystal balls and predict what the next 12 to 18 months might have in store. For most, the expectation was of a busy year for healthcare deals in 2024, thanks in part to pent up demand from both buyers and sellers, as well as significant dry powder sitting on the sidelines and keen to transact.
The healthcare private equity deal markets in Europe may not immediately return to the heady levels of 2021, but many in the industry feel there is plenty more investment activity to look forward to in the year ahead.

DOJ Unveils Voluntary Self-Disclosure Safe Harbor for M&A Deals
ARTICLE / CLIENT ALERT
DOJ Unveils Voluntary Self-Disclosure Safe Harbor for M&A Deals
October 17, 2023
Read time: 6 min
On October 4, 2023, during remarks before the Society of Corporate Compliance and Ethics, Deputy Attorney General (AG) Lisa Monaco unveiled a new US Department of Justice (DOJ)-wide safe harbor policy for voluntary self-disclosures made in connection with mergers and acquisitions (M&A). Under the policy, companies can avoid criminal prosecution if they voluntarily self-report misconduct discovered at the acquired company in a timely manner, remediate such misconduct within one year and cooperate with any ensuing DOJ investigation. The policy, which Principal Associate Deputy AG Marshall Miller previewed during remarks at the Global Investigations Review Annual Meeting in New York, builds upon related DOJ guidance from the past several years encouraging and incentivizing voluntary self-disclosure of criminal misconduct, particularly in the context of M&A.
VOLUNTARY SELF-DISCLOSURE SAFE HARBOR POLICY
The voluntary self-disclosure safe harbor policy is intended to provide significant benefits to companies that promptly self-report and remediate criminal misconduct uncovered in connection with “bona fide, arm’s length M&A transactions.” Deputy AG Monaco noted that the policy is designed to “incentivize the acquiring company to timely disclose misconduct uncovered during the M&A process.” Companies that satisfy the safe harbor’s requirements, as detailed below, are entitled to a presumption that the DOJ will decline to prosecute the acquiring company for the disclosed conduct. In contrast, companies that fail to voluntarily self-report and remediate criminal misconduct discovered at an acquired company in accordance with the policy may be subject to full successor liability for such misconduct under the DOJ’s corporate enforcement policy.
The new safe harbor policy will apply across the DOJ, with each department tailoring its application to “fit their specific enforcement regime” and considering how to implement the policy in practice. As Principal Associate Deputy AG Miller stated, the policy is part of a wider effort to “ensure consistency, transparency, and predictability in corporate criminal enforcement” across the DOJ.
REQUIREMENTS FOR APPLICATION OF VOLUNTARY SELF-DISCLOSURE SAFE HARBOR
For an acquiring company to avail itself of the safe harbor, it must do the following:
- Disclose misconduct at the acquired entity within six months from the date of closing, regardless of when the misconduct was discovered (i.e., pre- or post-acquisition);
- Remediate the misconduct within one year from the date of closing of the merger or acquisition; and
- Fully cooperate with any ensuing DOJ investigation.
Acknowledging that the facts, circumstances and complexities of M&A deals differ, the timelines for disclosure and remediation are subject to a “reasonable analysis.” The DOJ has indicated some willingness to extend or, in contrast, shorten these deadlines based on the facts and circumstances of any case. Similar to existing DOJ policy, voluntary self-disclosure does not apply to misconduct otherwise required to be disclosed or already known to the public or the DOJ.
Deputy AG Monaco also made clear that typical aggravating factors (e.g., egregious or pervasive misconduct, involvement of senior executives) will not impact whether an acquiring company receives a declination under the new policy, provided that the acquiring company otherwise meets all applicable criteria. Further, under the policy, an acquiring company’s voluntary self-disclosure of misconduct at the newly acquired company will not factor into the DOJ’s recidivist analysis in subsequent matters, meaning that an acquiring company would not be considered a recidivist—or otherwise have the disclosed conduct held against it—in any future engagements with the DOJ.
IMPORTANCE OF COMPLIANCE AND DUE DILIGENCE
Deputy AG Monaco noted that the DOJ is placing “an enhanced premium on timely compliance-related due diligence and integration,” highlighting the importance of having compliance personnel involved for an acquiring company to effectively de-risk an M&A transaction. Emphasizing this point, Deputy AG Monaco stated that the DOJ’s goal is for “good companies—those that invest in strong compliance programs—[to] not be penalized for lawfully acquiring companies when they do their due diligence and discover the self-disclosed misconduct.” Similarly, Principal Associate Deputy AG Miller previously stated that acquiring companies “should not be penalized when they engage in careful preacquisition diligence and timely post-acquisition integration to detect and remediate misconduct at the acquired company’s business.”
KEY TAKEAWAYS
- While pre- and post-close diligence has always been an integral part of any deal, the new voluntary self-disclosure policy and safe harbor provide meaningful parameters and a welcome degree of certainty for companies that discover potential areas of concern during the diligence process. Notably, the safe harbor will apply irrespective of whether the acquiring company identifies the problem before or after closing. Companies that are able to identify a problem pre-closing can now rely on the presumption of a declination should they be prepared to disclose the problem within six months of closing and remediate it within approximately one year of closing.
- Compliance in diligence remains key. While the safe harbor provides a positive path forward for companies whose pre- and post-diligence processes are robust and sufficient to detect potential problems, it provides no comfort to companies that fail to identify such problems in a timely fashion. The DOJ clearly expects the compliance function to have a seat at the table during the diligence process. For conduct not discovered before or shortly after closing, the DOJ may scrutinize the acquiring company’s diligence process and compliance function as part of any ensuing investigation.
- Post-closing diligence should not be overlooked. Acknowledging that not every problem can reasonably be discovered pre-closing, the DOJ has given companies a baseline of six months post-close to further explore areas of concern or to discover issues that may not have been previously disclosed. The DOJ has also indicated some willingness to extend that timeline depending on a consideration of any relevant facts and circumstances. Ensuring that a plan for post-closing diligence is established—and, in particular, that any issues or concerns identified pre-closing are promptly investigated—will be essential for preserving a company’s ability to even consider seeking safe harbor protection.

CFTC Proposes Rule 4.7 Changes That Would Impose Significant New Disclosure Requirements for Many CPO-Registered Fund Managers and CTA-Registered Advisers
ARTICLE / CLIENT ALERT
CFTC Proposes Rule 4.7 Changes That Would Impose Significant New Disclosure Requirements for Many CPO-Registered Fund Managers and CTA-Registered Advisers
October 17, 2023
Read time: 9 min
On Oct. 2, the Commodity Futures Trading Commission (“CFTC”) proposed amendments (“Proposal”)[1] to Rule 4.7, the primary disclosure, reporting and recordkeeping relief relied upon by CFTC-registered commodity pool operators (“CPOs”) and commodity trading advisers (“CTAs”). Rule 4.7 is most commonly relied upon by managers serving sophisticated investors whose portfolios include substantial exposure to derivatives; these proposals would significantly increase applicable disclosure requirements, mandating the inclusion of certain performance information and break-even expense analysis. The proposed amendments also include changes to Rule 4.7’s investor suitability criteria, which are not expected to have as widespread of an impact on fund managers given that these thresholds will not affect managers whose funds are offered to “qualified purchasers” for Investment Company Act exemptive purposes. The technical effect of these proposals on the Rule 4.13(a)(3) (“de minimis”) relief relied on by many fund managers to remain exempt from CPO registration is also expected to be moot.
The CFTC has solicited comments on its published Proposal, which will be due by Monday, Dec. 11.
Background
A registered CPO that offers a fund in full compliance with Part 4 of the CFTC’s rules must include a variety of required disclosures and prescribed content in the fund’s offering documents. Rule 4.7 currently exempts a registered CPO from nearly all of those requirements, so long as interests in the fund are offered to sophisticated investors who qualify as Qualified Eligible Persons (“QEPs”). A similar framework applies to managed account advisers who are registered as CTAs with respect to account clients who are QEPs. Managers whose commodity interest trading falls below a de minimis threshold are eligible to avoid registration as a CPO in reliance on the 4.13(a)(3) exemption.
Major Changes
Disclosure Requirements
The CFTC’s Oct. 2 amendments effect several technical changes to Rule 4.7 and also codify certain prior no-action relief for the timing of quarterly account reporting for funds of funds. However, by far the most consequential changes are those to the disclosure requirements of Rule 4.7, which would subject private placement memoranda and account brochures delivered in compliance with Rule 4.7 to important parts of the detailed disclosure provisions of CFTC Part 4. Most relevant for managers will be the new disclosure requirements for registered CPOs under certain provisions of CFTC Rule 4.24 (“General Disclosures Required”):[2]
- A description of principal risk factors for the exempt pool, as required by Rule 4.24(g);
- A description of the exempt pool’s investment program and use of proceeds, as required by Rule 4.24(h);
- A description of fees and expenses, as required by Rule 4.24(i);
- A description of conflicts of interest, as required by Rule 4.24(j); and
- Performance disclosures, as required by Rule 4.25 (“Performance Disclosures”), with the exception of information required by paragraphs (a)(3) and (c)(2) (involving performance of the commodity pool operator’s other investment programs) of Rule 4.25.
While managers already typically include a recitation of principal risk factors, a description of the investment program and conflicts of interest disclosures in fund offering documents, the required break-even[3] expense analysis under CFTC Rule 4.24(i) and capsule performance disclosures of CFTC Rule 4.25 are new requirements that will require significant revisions to offering memoranda. Required disclosures under Rule 4.25 include, for instance:
- The largest monthly draw-down during the most recent five calendar years and year-to-date, expressed as a percentage of the pool’s net asset value and indicating the month and year of the draw-down;
- The worst peak-to-valley draw-down during the most recent five calendar years and year-to-date, expressed as a percentage of the pool’s net asset value and indicating the months and year of the draw-down; and
- The annual and year-to-date rate of return for the pool for the most recent five calendar years and year-to-date, computed on a compounded monthly basis.
The CFTC will also require managers to keep these disclosures current: The CFTC has proposed largely rescinding the current exemption from CFTC Rule 4.26 (“Use, amendment and filing of Disclosure Document”), including CFTC Rule 4.26(a)[4], and subject managers will be unable to use disclosure documents older than 12 months. Moreover, the newly required disclosure documents will become subject to the CFTC’s recordkeeping rules.
Notably, the CFTC did not make offering memoranda or account brochures subject to National Futures Association (“NFA”) pre-approval, a process that is required for a fully Part 4-compliant fund. However, managers should expect the review of these disclosures to be a part of the NFA exam process and it is not yet clear whether the new rules, if adopted, will include an implementation period. The CFTC has requested comment on this point. Also to be determined is whether the CFTC will require managers to provide existing investors with updated disclosures before new subscriptions are made.
Updates to QEP Standard — Inflation Adjustment Increases to Portfolio Requirement Thresholds
The CFTC has also proposed increasing the financial thresholds (“Portfolio Requirement”) for certain investors to count as QEPs, the classification of investors eligible to participate in a Rule 4.7 vehicle. In the CFTC’s view, this increase is warranted due to the effects of inflation since the current thresholds were established. These requirements would only apply to new subscriptions, including by existing investors; managers would not be forced to redeem existing investors who do not meet the updated requirements.
These changes will affect a smaller universe of fund managers; they will not affect private funds offered pursuant to Section 3(c)(7) for Investment Company Act exemptive purposes, as qualified purchasers are not required to satisfy these Portfolio Requirement thresholds. Non-US Persons similarly are not required to meet the Portfolio Requirement.
QEPs fall into two categories — those subject to a “Portfolio Requirement” as outlined in paragraphs (a)(1)(v) and (c)(3) of Rule 4.7 itself, and those exempt from this test in view of some other status (most importantly, non-US Persons and Qualified Purchasers). Under the CFTC’s proposal, new subscriptions for investors subject to the Portfolio Requirement will face doubled financial thresholds to count as QEP investments.
|
|
Current Thresholds |
Proposed QEP Thresholds |
|
Asset Threshold: owning securities and other assets of the stipulated value. |
$2 million |
$4 million |
|
Deposit Threshold: having on deposit with a futures commission merchant for their own account at least the stipulated amount in initial margin, option premiums or minimum security deposits. |
$200,000 |
$400,000 |
As under the current definition, an investor may also satisfy the “Portfolio Requirement” by owning a portfolio of funds and assets that, when expressed as percentages of the prior two thresholds, have a combined value of at least 100 percent.
Implications and Action Steps
Affected managers should begin considering the impact of the CFTC’s Proposal now.
- Most importantly, subject managers should familiarize themselves with the proposed Rule 4.7 disclosure requirements, particularly the incorporated provisions of CFTC Rule 4.25 (concerning past performance) and Rule 4.24(i) (concerning the break-even fee and expense analysis), and confirm that they will be prepared to produce these additional disclosures. Again, it is unclear whether managers will enjoy an implementation period, and whether updated disclosures will need to be delivered for Rule 4.7 funds not actively soliciting subscriptions.
- Aside from pro forma updates to subscription documents, managers who operate Section 3(c)(7) funds and rely on Rule 4.7 will be unaffected by the changes to the QEP definition, as they collect Qualified Purchaser representations already, and Qualified Purchasers are QEPs not subject to the Portfolio Requirement. Managers of Section 3(c)(1) vehicles, however, will need to ensure that they are prepared to collect updated QEP representations for any future subscriptions subject to the revised Portfolio Requirement.
- Operators of Rule 4.13(a)(3) funds are unlikely to be substantively affected by the new QEP thresholds, as the Rule 4.13(a)(3) exemption is satisfied by the Accredited Investor thresholds which are lower than those for the QEP definition.[5]
Authored by Heather N. Wyckoff and Joshua B. Wright.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] See Commodity Pool Operators, Commodity Trading Advisers, and Commodity Pools: Updating the ‘Qualified Eligible Person’ Definition; Adding Minimum Disclosure Requirements for Pools and Trading Programs; Permitting Monthly Account Statements for Funds of Funds; Technical Amendments, 88 FR 70852, accessible here.
[2] The CFTC has adopted parallel amendments to the Rule 4.34 disclosure exemption applicable to CTAs relying on Rule 4.7, but due to the interaction of several generous CTA registration exemptions, including Commodity Exchange Act Section 4m(1) and CFTC Rule 4.14(a)(10) (exemptions for managers with a de minimis number of advisery clients), and Rule 4.14(a)(5) (an exemption from CTA registration for registered CPOs with respect to their advised pools) few managers serving sophisticated investors are required to register as CTAs.
[3] Here, “break even” refers to the trading profit that a pool must realize in the first year of a participant’s investment to equal all fees and expenses such that the pool participant will recoup its initial investment.
[4] CFTC Rule 4.26(a) provides that 1) all information contained in the required disclosure document must be current as of the date of the document, provided that performance information may be current as of a date not more than three months prior to the date of the document, and 2) that CPOs may not use a disclosure document dated more than twelve months prior to its date of use.
[5] The Accredited Investor thresholds and QEP Portfolio Requirement are not expressed in precisely identical terms, but all Accredited Investors are eligible to participate in Rule 4.13(a)(3) vehicles under CFTC Rule 4.13(a)(3)(iii)(A).
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2023 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

SEC Adopts Amendments to Beneficial Ownership Reporting Rules
ARTICLE / CLIENT ALERT
SEC Adopts Amendments to Beneficial Ownership Reporting Rules
October 16, 2023
Read time: 6 min
On October 10, 2023, the US Securities and Exchange Commission (SEC) adopted amendments to Sections 13(d) and 13(g) of the Securities Exchange Act of 1934, which among other things, accelerate the filing deadlines for Schedules 13D and 13G. In announcing these changes, SEC Chairman Gary Gensler stated that the old reporting requirements did not reflect the current pace of information in the modern capital markets, and the changes to the Schedule 13D and 13G reporting rules would “reduce information asymmetries.” The amendments and revised Schedule 13D deadline will become effective 90 days after publication of the amendments in the Federal Register. Compliance with the revised Schedule 13G filing deadlines will be required beginning September 30, 2024, and compliance with the structured data requirements for Schedule 13D and 13G will be required beginning December 18, 2024.
Sections 13(d) and 13(g) require persons or groups who own or acquire beneficial ownership of more than 5% of certain classes of “equity securities” registered under the Exchange Act to file ownership reports with the SEC. Currently, a Schedule 13D is required to be filed within 10 calendar days of the acquisition of more than 5% of a class of securities. A Schedule 13G is generally required to be filed annually, within 45 days of the end of the calendar year in which the investor’s beneficial ownership exceeds 5% of a class of securities or, for certain passive investors, within 10 calendar days of the acquisition of more than 5% of a class of securities.
ACCELERATED FILING DEADLINES
Schedule 13D:
- The amendments shorten the initial filing deadline from 10 calendar days to five business days and require that amendments to Schedule 13D be filed within two business days. The current rules only require that amendments be filed “promptly.”
Schedule 13G:
- For certain qualified institutional investors filing under Rule 13d-1(b) (such as registered broker-dealers, registered investment advisers or registered investment companies) and exempt investors (investors filing under Rule 13d-1(d) because they own more than 5% but have not made an acquisition subject to Section 13(d), such as founders and other pre-initial public offering investors), the amendments shorten the initial filing deadline from 45 calendar days after the calendar year-end to 45 calendar days after the end of the calendar quarter in which the investor beneficially owns more than 5% of the covered class.
- For passive investors (investors who own less than 20% and do not hold with the purpose or effect of changing or influencing control of the issuer) filing under Rule 13d-1(c), the amendments shorten the initial filing deadline from 10 calendar days to five business days.
- The amendments require that an amendment be filed 45 calendar days after the calendar quarter in which a material change occurred rather than 45 calendar days after the calendar year in which any change occurred.
- Upon exceeding 10% beneficial ownership of a covered class, the amendments require that (1) qualified institutional investors file an amendment within five business days after the end of the month in which they cross the 10% threshold and (2) passive investors file an amendment within two business days of acquiring more than 10%.
The amendments also extend the Electronic Data Gathering, Analysis and Retrieval (EDGAR) submission deadline for Schedule 13D and 13G filings to the SEC, adjusting it from 5:30 pm to 10:00 pm (ET).
DERIVATIVE SECURITIES
Generally, the amendments deem holders of certain cash-settled derivative securities as beneficial owners of the reference equity securities and clarify the disclosure requirements of Schedule 13D with respect to derivative securities.
Beneficial Ownership: Rather than adopt proposed Rule 13d-3(e), which would have deemed holders of certain cash-settled derivative securities as beneficial owners of the reference covered class, the SEC referred to the Security-Based Swaps Release to determine the circumstances under which a holder of a security-based swap may become a beneficial owner. Pursuant to the release, a holder may be required to report beneficial ownership where a security-based stock (1) confers voting and/or investment power, (2) is used as part of a plan or scheme to evade reporting requirements, or (3) grants a right to acquire beneficial ownership of the equity security within 60 days or with the purpose or effect of changing or influencing control of the issuer.
Disclosure of Interest: To eliminate any ambiguity regarding the scope of the disclosure obligations of Schedule 13D’s Item 6 as to derivative securities, the amendments revise Item 6 to clarify that a person is required to disclose interests in all derivative securities that use the issuer’s equity security as a reference security, including cash-settled derivatives.
GROUP FORMATION AND EXEMPTIONS
Under Rule 13d-5(b)(1) of the Exchange Act, whenever two or more persons agree to act together for the purpose of acquiring, holding, voting or disposing of an issuer’s equity securities, the group is deemed to have acquired beneficial ownership of all of the issuer’s equity securities that are beneficially owned by any member of the group as of the date they agreed to form the group.
Group Formation: The SEC provided guidance as to the existing legal standard established in Sections 13(d)(3) and 13(g)(3). The SEC clarified that a group can be formed when two or more persons take concerted actions for the purpose of acquiring, holding or disposing of an issuer’s securities, even in the absence of an express agreement.
STRUCTED DATA REQUIREMENTS
The amendments require that Schedule 13D and 13G reports be filed using a structured, machine-readable data language. Schedules 13D and 13G are required to be filed in part using an XML-based language specific to Schedules 13D and 13G, including all disclosures, textual narratives and identification checkboxes (except for exhibits to the Schedules).
If you have any questions about the SEC’s amendments, please reach out to the authors of this article or your regular McDermott lawyer.
Marisa Montoya, a law clerk in the Chicago office, also contributed to this article.

Understanding the Corporate Transparency Act’s Company Reporting Obligations
ARTICLE / CLIENT ALERT
Understanding the Corporate Transparency Act’s Company Reporting Obligations
October 16, 2023
Read time: 6 min
Beginning January 1, 2024, the US Corporate Transparency Act (CTA) will require “reporting companies” to submit a report to the Financial Crimes Enforcement Network (FinCEN) containing personal information about the reporting company’s “beneficial owners.” Reporting companies formed before January 1, 2024, will have until January 1, 2025, to file their initial report with FinCEN. Willful failure to comply with reporting obligations can result in steep financial penalties. Proposed regulations issued on September 27, 2023, extend the period for which reporting companies formed on or after January 1, 2024, and before January 1, 2025, must file their initial report to within 90 days of the company’s formation. Reporting companies formed on or after January 1, 2025, must file an initial report within 30 days of the company’s formation.
“REPORTING COMPANIES” AND THE INFORMATION THEY HAVE TO REPORT
Only “reporting companies” are subject to the CTA’s reporting requirements. A “reporting company” includes (1) any corporation, LLC, limited partnership or similar entity created by filing a document with any US state, territory or Indian tribe (domestic reporting companies), and (2) any non-US entity that registers to do business with any US state, territory or Indian tribe (foreign reporting companies). Trusts (other than trusts created by a filing, such as statutory or business trusts) are themselves not reporting companies.
On September 30, 2022, the US Department of the Treasury (Treasury) issued final regulations detailing what information must be reported to FinCEN. Generally, reporting companies must provide information on the reporting company itself, its “beneficial owners” and its “company applicants” (with the company applicant reporting only relevant for entities formed on or after January 1, 2024).
- Reporting Company: Each reporting company must provide the company’s legal name, trade name or “doing business as” name, current address, the company’s jurisdiction of formation (or, for a foreign reporting company, the state, territory or tribal jurisdiction where it first registers) and the company’s EIN. Foreign reporting companies must provide a foreign tax identification number if they do not have an EIN.
- Beneficial Ownership Information (BOI): Reporting companies must identify each of their “beneficial owners.” A “beneficial owner” is any individual who, directly or indirectly, exercises “substantial control” over the reporting company OR who “owns” or “controls” at least 25% of the “ownership interests” in a reporting company (ownership interests include equity, stock, or voting rights, capital or profit interests, convertible instruments, options, and any other instrument, contract, or other mechanism used to establish ownership). The regulations provide guidance for “substantial control” and “owns or controls.” For example, an individual has substantial control if such individual exercises a certain degree of power over a reporting company, like serving as a senior officer (e.g., president, chief executive officer, chief financial officer or general counsel) for the company. This definition is broad and can include anyone who has the authority to appoint or remove certain officers or a majority of directors or who has direction or substantial influence over important matters at the reporting company, such as compensation schemes and incentive programs for senior officers. A reporting company can have multiple beneficial owners and will always have at least one person that is reportable under the “substantial control” prong of the beneficial owner tests.
- Company Applicants: Up to two “company applicants” must be identified for reporting companies formed on or after January 1, 2024. The two company applicants include (1) the individual who directly files the document to create or register the reporting company, and (2) the individual who is primarily responsible for directing or controlling such filing (if more than one individual participates in the filing). For example, Individual A, who wants to create a company, prepares the necessary formation documents and directs Individual B to file the documents with the relevant state office. Individuals A and B are both company applicants—Individual B directly filed the documents, and Individual A was primarily responsible for directing or controlling the filing.
For every beneficial owner and company applicant, the report must include the individual’s full legal name, date of birth, current residential address (or business address for a company applicant if in the business of forming entities), and an “identifying number” and “image” from documents like a US passport, US driver’s license, US identification card or, if no US-issued document is available, a foreign passport.
Reporting companies may in certain instances report a “FinCEN identifier” instead of the information for an individual beneficial owner or company applicant. A FinCEN identifier is a unique identifying number that FinCEN will issue to individuals or entities upon request. A FinCEN identifier could facilitate easier reporting for reporting companies and additional privacy/protection for individuals and allow for fewer updated reports to be filed by reporting companies (which are generally required for changes in reporting company information or BOI within 30 days of the change).
EXCEPTIONS TO THE CTA REPORTING REQUIREMENTS
The CTA and the regulations provide 23 exemptions from the reporting company definition. These exemptions generally apply to highly regulated businesses, including:
- Banks: Banks, as defined in the regulations, are excluded from the reporting company definition. Some other bank-type entities are also excluded, such as regulated private trust companies.
- Large Operating Companies: The regulations generally define large operating companies as companies that (1) have more than 20 full-time employees in the US, (2) have an operating presence at a physical office within the US, AND (3) have filed a federal income tax or information return in the US for the previous year demonstrating more than $5,000,000 in gross receipts or sales (excluding gross receipts or sales from sources outside the US). Meeting the 20 full-time employees requirement is tested on a per-entity basis, but the gross receipts or sales reported on the tax return requirement can be measured based on the reported gross receipts or sales of a consolidated group on a consolidated tax return.
- Publicly Traded Companies: The regulations exempt issuers of securities registered under Section 12 of the Securities Exchange Act of 1934 and issuers of securities required to file supplementary or periodic information under Section 15(d) of the Securities Exchange Act of 1934.
- Tax-Exempt Entities: Tax-exempt entities, as defined in the regulations, generally include organizations described in Internal Revenue Code (IRC) Section 501(c) and exempt from tax under IRC section 501(a).
PENALTIES
The CTA applies civil and criminal penalties for willfully (1) failing to report or update a reporting company’s BOI and (2) providing false or fraudulent BOI. Civil penalties include a daily $500 fine for a continuing violation, up to a maximum of $10,000. Criminal penalties include up to two years’ imprisonment. The CTA does not contain any provision for non-willful or negligence penalties.
If you have questions about the implications of the CTA and reporting obligations, please do not hesitate to contact the authors of this article or your regular McDermott lawyer(s).

California Raises Minimum Wages for Healthcare Workers, Effective June 1, 2024
ARTICLE / CLIENT ALERT
California Raises Minimum Wages for Healthcare Workers, Effective June 1, 2024
October 16, 2023
Read time: 11 min
On October 13, 2023, California Governor Gavin Newsom signed California Senate Bill No. 525 (SB 525) into law. Effective June 1, 2024, the law raises the minimum wage for California healthcare employees and sets a new salary threshold for who is considered an exempt healthcare employee (and exempt from overtime).
WHAT HEALTHCARE FACILITIES ARE COVERED?
The scope of SB 525 is vast, covering nearly all healthcare facilities operating in California. This includes:
- A facility or other work site that is part of an integrated healthcare delivery system;
- (Several of the facility types are further defined in the statute, which can be found here: https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202320240SB525)
- A licensed general acute care hospital, as defined Section 1250(a) of the Health and Safety Code, including a distinct part of any such hospital (including rural general acute care hospitals);
- (All statutory section references in this article are to the Health and Safety Code unless otherwise specified)
- A licensed acute psychiatric hospital, as defined in Section 1250(b), including a distinct part of any such hospital;
- A special hospital, as defined in Section 1250(f);
- A licensed skilled nursing facility (including small house skilled nursing facility);
- A patient’s home when healthcare services are delivered by an entity owned or operated by a general acute care hospital or acute psychiatric hospital;
- A licensed home health agency, as defined in Section 1727(a);
- A clinic, as defined in Section 1204(b) (including a specialty care clinic, a dialysis clinic, a surgical clinic, a rehabilitation clinic or an alternative birth center);
- A psychology clinic, as defined in Section 1204.1;
- A clinic as defined in Section 1206(d), (g) or (l);
- A licensed residential care facility for the elderly, as defined in Section 1569.2, if affiliated with an acute care provider or owned, operated or controlled by a general acute care hospital, acute psychiatric hospital, or the parent entity of a general acute care hospital or acute psychiatric hospital;
- A psychiatric health facility, as defined in Section 1250.2;
- A mental health rehabilitation center, as defined in Section 5675 of the Welfare and Institutions Code;
- A community clinic licensed under Section 1204(a), an intermittent clinic exempt from licensure under Section 1206(h), or a clinic operated by the state or any of its political subdivisions, including—but not limited to—the University of California or a city or county that is exempt from licensure under Section 1206(b);
- A rural health clinic, as defined in 42 U.S.C. 1396d(l)(1);
- An urgent care clinic (i.e., a facility or clinic that provides immediate, nonemergent ambulatory medical care to patients, including—but not limited to—facilities known as walk-in clinics or centers or urgent care centers);
- An ambulatory surgical center that is certified to participate in the Medicare Program under Title XVIII (42 U.S.C. Sec. 1395, et seq.) of the federal Social Security Act;
- A physician group (i.e., a medical group practice, including a professional medical corporation, as defined in Section 2406 of the Business and Professions Code, another form of corporation controlled by physicians and surgeons, or a medical partnership, provided that the group includes a total of 25 or more physicians);
- A county correctional facility that provides healthcare services; and
- A county mental health facility.
“Health care services” is also defined broadly to mean patient care-related services, including: nursing; caregiving; services provided by medical residents, interns or fellows; technical and ancillary services; janitorial work; housekeeping; groundskeeping; guard duties; business office clerical work; food services; laundry; medical coding and billing; call center and warehouse work; scheduling; and gift shop work; but only where such services support patient care.
SB 525 does not cover hospitals owned, controlled or operated by the Department of State Hospitals or tribal clinics exempt from licensure under Section 1206(c), or an outpatient setting conducted, maintained or operated by a federally recognized Indian tribe, tribal organization or urban Indian organization, as defined in 25 U.S.C. 1603.
WHAT WORKERS ARE COVERED?
SB 525 applies to the following types of workers:
- An employee of a healthcare facility employer who provides patient care, healthcare services or services supporting the provision of healthcare;
- A contracted or subcontracted employee if (i) the employee’s employer contracts with the healthcare facility employer, or with a contractor or subcontractor to the healthcare facility employer, to provide healthcare services, or services supporting the provision of healthcare, and (ii) the healthcare facility employer directly or indirectly, or through an agent or any other person, exercises control over the employee’s wages, hours or working conditions; and
- All employees performing contracted or subcontracted work primarily on the premises of a covered healthcare facility to provide healthcare services or services supporting the provision of healthcare.
The types of workers that the law covers are expansive. This includes (without limitation) employees performing work in the occupation of a nurse, physician, caregiver, medical resident, intern or fellow, patient care technician, janitor, housekeeping staff person, groundskeeper, guard, clerical worker, nonmanagerial administrative worker, food service worker, gift shop worker, technical and ancillary services worker, medical coding and medical billing personnel, scheduler, call center and warehouse worker, and laundry worker, regardless of formal job title.
However, the law contains specific carve-outs and does not apply to:
- Employment as an outside salesperson;
- Any work performed in the public sector where the primary duties performed are not healthcare services;
- Delivery or waste collection work on the premises of a covered healthcare facility, provided that the delivery or waste collection worker is not an employee of any person that owns, controls or operates a covered healthcare facility; or
- Medical transportation services in or out of a covered healthcare facility, provided that the medical transportation services worker is not an employee of any person that owns, controls or operates a covered healthcare facility.
CHANGES TO MINIMUM WAGE EFFECTIVE JUNE 1, 2024
SB 525 creates the following minimum wage schedules for covered employees, depending on different categories of healthcare facilities:
| Healthcare Facility Category* | June 1, 2024, to May 31, 2025 | June 1, 2025, to May 31, 2026 | June 1, 2026 | Further Adjustments |
|---|---|---|---|---|
| Covered healthcare facility employer: (i) with 10,000+ full-time equivalent employees; (ii) that is a part of an integrated healthcare delivery system or healthcare system with 10,000 or more full-time equivalent employees; (iii) that is a dialysis clinic under Section 1204(b) or that is a person that owns, controls or operates a dialysis clinic; or (iv) that is owned, affiliated or operated by a county with a population of more than 5,000,000 as of January 1, 2023 | $23 | $24 | $25, and until adjusted | TBD |
| Hospital with a high governmental payor mix, independent hospital with an elevated governmental payor mix, a rural independent covered healthcare facility, or a covered healthcare facility that is owned, affiliated, or operated by a county with a population of less than 250,000 as of January 1, 2023 | $18 | $18.63 | $19.28 (and 3.5% increases annually) | Beginning June 1, 2033, and until adjusted, $25 |
| Clinics as defined in Section 1206(h) not operated or affiliated with a clinic described in Section 1206(b), community clinics licensed under Section 1204(a) and any associated intermittent clinic exempt from licensure under Section 1206(h), a rural health clinic that is not license-exempt, or an urgent care clinic owned and affiliated with such community or rural health clinic | $21 | $21 | $22 | Beginning June 1, 2027, and until adjusted, $25 |
| Other covered healthcare facilities (including licensed skilled nursing facilities) | $21 | $21 | $23 | Beginning June 1, 2028, and until adjusted, $25 |
*A covered healthcare facility that is county-owned, affiliated or operated would not be required to comply with SB 525 until January 1, 2025.
By January 31, 2024, the Department of Health Care Access and Information will publish online: (1) a list of all covered healthcare facility employers with 10,000 or more full-time equivalent employees, or covered healthcare facility employers that are part of an integrated delivery system or healthcare system with 10,000 or more full-time equivalent employees; and (2) a list of all hospitals that qualify as a hospital with a high governmental payor mix, an independent hospital with an elevated governmental payor mix or a rural independent covered healthcare facility. Any facility that believes they have been misclassified and wishes to be reclassified must file a request with the Department of Health Care Access and Information to be reclassified properly no later than January 31, 2025.
CHANGES IN EXEMPT SALARY THRESHOLD
SB 525 establishes that for exempt healthcare employees paid on a salary basis, a covered employee’s monthly salary shall be no less than 150% of the applicable healthcare worker minimum wage or 200% of the minimum wage (under the Labor Code section 1182.12), whichever is greater.
WAIVER PROGRAM FOR CLINICS
By March 1, 2024, the Departments of Industrial Relations, Health Care Services and Health Care Access and Information will develop a waiver program for the following covered healthcare facilities:
- Clinics as defined in Section 1206(h) not operated or affiliated with a clinic described in Section 1206(b);
- Community clinics licensed under Section 1204(a) and any associated intermittent clinic exempt from licensure under Section 1206(h);
- Rural health clinics that are not license-exempt; and
- Urgent care clinics owned and affiliated with such community or rural health clinics.
The waiver program would authorize these covered healthcare facilities to apply for and receive a temporary pause or alternative phase-in schedule of the healthcare minimum wage requirements under the law.
A waiver, if granted, would be for a term of one year from the date of issuance, subject to renewal by request from the facility and approval by the agencies. To obtain a waiver, a covered healthcare facility will be required to demonstrate that compliance with the law would raise doubts about the covered healthcare facility’s ability to continue as a going concern under generally accepted accounting principles, including evidentiary documentation of the facility’s financial condition, as well as the condition of any parent or affiliated entity, and evidence of the actual or potential direct financial impact of compliance with the law. The agencies will consider the following factors:
- Actual or likely closure of the covered healthcare facility or any affiliated entity;
- Actual or likely closure of patient services or programs;
- Actual or likely loss of jobs;
- Whether the covered healthcare facility is small, rural, frontier or serves a rural catchment area;
- Whether closure of the covered healthcare facility would significantly impact access to services in the region or service area; and
- Whether the covered healthcare facility is in financial distress that results, or is likely to result, in the closure of the covered healthcare facility or any affiliated entity, closure of patient services or programs, or loss of jobs. Factors to consider in determining financial distress include, but are not limited to, the covered healthcare facility’s prior and projected performance on financial metrics, including the amount of cash on hand, and whether the covered healthcare facility has, or is projected to, experience negative operating margins.
PENALTIES FOR NONCOMPLIANCE
SB 525 provides a private right of action for any covered employees to enforce the minimum wage requirement. Therefore, we expect healthcare employees to institute civil litigation including via class actions to enforce claims such as failure to pay minimum wage, failure to pay overtime wage, derivative claims including wage statement and waiting time penalties, and claims associated with misclassification of exempt employees. In addition, we expect the state Department of Industrial Relations to institute enforcement actions via random audits and pursuant to employee complaints.
MORATORIUM ON LOCAL COMPENSATION ORDINANCES
SB 525 also prohibits any city or county from enacting or enforcing an ordinance, regulation or administrative action that would impose compensation requirements or limitations on any covered healthcare facility. This prohibition, among other things, negates the ballot initiatives that had been promoted in Los Angeles County, San Diego County and various California cities to impose a cap on the compensation that could be paid to any employee of a covered healthcare facility (for example, in Los Angeles County, the proposed cap was equal to the annual salary of the US president). These ballot initiatives were widely viewed as imposing severe restrictions, if passed, on the ability of hospitals and healthcare systems to pay competitive compensation to their executive leaders. SB 525 places its moratorium on separate local compensation ordinances through the end of 2029 (with an additional moratorium on separate local minimum wage ordinances for covered healthcare facility employees through 2033).
KEY TAKEAWAYS
SB 525 is the nation’s first law creating a statewide healthcare worker minimum wage standard and the first to raise the minimum wage to $25 per hour. The law preempts any local ordinances setting wages for healthcare workers (cities and counties can still set industry-agnostic wage standards).
Healthcare employers and contractors that employ workers who provide services at healthcare facilities should consider the following steps to stay in compliance with the new law:
- Evaluate which category of healthcare-covered employer you fall within and determine which minimum wage increase schedule applies;
- Conduct an audit of employees’ hourly wages and salaries to determine if current wage rates meet the new SB 525 thresholds for hourly and salaried exempt employees; and
- Implement a compliance plan to adjust wages as needed before June 1, 2024, and/or begin gathering documentation to support a temporary exemption request via the waiver program (for certain clinics only).
Healthcare and other industry-specific laws continue to gain traction at the state and local levels as labor unions push for these changes, which come at a time of increased organizing campaigns and changes to the way unions can be elected. Employers should continue to closely collaborate with legal counsel as they focus on employee relations and long-term compliance strategies.

Fast Food ‘False Advertising’ Deemed Puffery, but Class Actions Persist
ARTICLE / CLIENT ALERT
Fast Food ‘False Advertising’ Deemed Puffery, but Class Actions Persist
October 13, 2023
Read time: 5 min
Although the plaintiffs’ class action bar has been filing false advertising claims at a record pace, encouraging news for consumer goods companies has come out of the courts. Companies can take some comfort knowing that broad false advertising claims could be reined in. Wendy’s and McDonald’s recently emerged victorious from a class action lawsuit launched against them in 2022. The plaintiff and the purported class accused the two fast food companies of unfair and deceptive trade practices and falsely advertising the size and appearance of food items on their menus. Stating that the advertising claims in question were mere puffery, the district judge dismissed all claims and denied leave to amend. This thorough decision could signal courts taking a welcomed approach to identifying puffery and thoughtfully analyzing advertising claims.
FALSE ADVERTISING
All advertising—regardless of the platform—must comply with basic advertising requirements. First, all advertisements must be true, and all claims made in an advertisement must be adequately substantiated. Claims made in an advertisement include express claims, comparative claims and implied claims, in addition to any claims created by the net impression of the ad.
Generally speaking, “puffery” is a statement or claim a person could not reasonably rely upon—i.e., the “best product in the entire galaxy.” Puffery is a concept in advertising in which advertisers use words or images with the intention of attracting or enticing more consumers to a product, as opposed to intentionally deceiving them about a fact. Puffery is typically acceptable in advertising. Claims that are considered puffery do not require substantiation and cannot be the basis for a successful false advertising claim.
To bring a claim for false advertising, which is an actionable civil claim under Section 43(a) of the Lanham Act and under many state laws that mirror the federal legislation, a plaintiff must generally show the following:
- The defendant made false, deceptive or misleading statements or claims regarding its products;
- Actual deception occurred, or at least a tendency to deceive a substantial percentage of the intended audience existed;
- The deception was material such that it was likely to influence consumer purchase decisions;
- The advertised goods traveled in interstate commerce; and
- Injury to the plaintiff was likely.
The plaintiff need not show that it suffered actual injury from the defendant’s allegedly false advertising. Puffery is not considered false advertising, because to be found liable for false advertising, the defendant must convey a specific statement of fact about a product that is false, misleading or deceptive, while puffery conveys a message that could not reasonably be relied upon.
CHIMIENTI V. WENDY’S INTERNATIONAL LLC, ET AL.
In the recently dismissed action, plaintiff Chimienti’s complaint specifically alleged that the companies materially overstated the size of their beef patties and toppings and therefore sold smaller-than-advertised burgers to customers. Chimienti further claimed that the companies used undercooked burger patties in their advertisements because “fully cooked burgers tend to shrink and look less appetizing.” He claimed that the companies’ advertisements damaged customers because “[customers] are receiving food that is much lower in value than what is being promised.”
Both Wendy’s and McDonald’s filed motions to dismiss the complaint in September 2022. They noted that customers “know what they are going to receive when they order a hamburger,” and that “it is common sense that actual food products from a quick service restaurant may not appear identical to their professionally photographed marketing images.”
On September 30, 2023, US District Judge Hector Gonzalez agreed with the companies’ position. He held there was no proof that the fast food giants sold smaller burgers than those advertised to their customers and that Chimienti did not adequately allege that he was injured by the companies’ advertisements, “since he does not allege that he ever saw them, and because he has failed to allege that the advertisements were materially misleading.” Judge Gonzalez cited the companies’ websites, which prominently displayed images of the burgers with the weight and calories of the meals and deemed McDonald’s and Wendy’s advertisements to be mere puffery. In his dismissal order, Judge Gonzalez further stated that the companies make their burgers look more appealing in advertisements just as other companies use models to make products more visually attractive, and he held that the plaintiff here failed to prove that a reasonable consumer would be misled by the advertisements. Thus, the court held that the two companies could continue to run their advertisements that present their burgers as meatier and juicier than they are when served in their restaurants.
TAKEAWAYS
With similar class actions currently pending, this decision is a welcome statement on the presence of puffery in the advertisement of consumer goods. The court’s holding in Chimienti v. Wendy’s is one of many decisions that will hopefully help rein in the aggressive plaintiffs’ class action bar when it comes to false advertising. While this dismissal is helpful for consumer goods companies, corporations should remain diligent in designing their advertising campaigns amid the ever-increasing focus of the plaintiffs’ bar on false advertising claims, and they should ensure that any claims made are backed by sufficient substantiation.

OHCA Updates Draft Regulations on California Healthcare Transaction Notice Requirement
ARTICLE / CLIENT ALERT
OHCA Updates Draft Regulations on California Healthcare Transaction Notice Requirement
October 13, 2023
Read time: 7 min
Earlier this week, California’s Office of Health Care Affordability (OHCA) published a revised draft of regulations related to the new transaction notice requirement that will apply to healthcare transactions closing on or after April 1, 2024. (Review the clean version of the revised regulations, or the version showing changes.)
Entities entering into healthcare transactions in California that will close on or after April 1, 2024, should be aware of these updated requirements to provide 90 days’ notice of certain material changes. They should also take note of the potential burdensome review process that could delay the closing of such transactions by several months.
OHCA is accepting public comments on the revised draft of the regulations through October 17, 2023, at 5 pm PST, and plans to promulgate final regulations in November.
OVERVIEW: TRANSACTION NOTICE REQUIREMENT
As we described in our prior On the Subject, “California Publishes Draft Regulations on Filing Requirement for Healthcare Entity Transactions,” California Senate Bill 184 requires a healthcare entity (defined as a provider, payor or fully integrated delivery system) to provide at least 90 days’ notice to OHCA prior to the closing of a transaction in which it sells—or transfers control of a material amount of—its assets or operations.
After the healthcare entity (also called a “submitter”) provides notice, the agency has 60 days to either advise the healthcare entity of its determination to conduct a cost and market impact review (CMIR) or provide a written waiver from such review. OHCA will issue a preliminary report upon completion of the CMIR. Then, after allowing the parties and the public to provide input, OHCA will issue its final report. No transaction going through the CMIR process may close until 60 days after OHCA issues the final report. Certain healthcare transactions involving review by the California Attorney General, Department of Managed Health Care or Insurance Commission, along with county transactions , are exempt from the notice requirement.
REVISED DRAFT OF THE REGULATIONS
Our prior On the Subject summarizes the notice requirement established by the statute and the initial draft of the regulations dated July 27, 2023. Following a public hearing and public comment period, OHCA published a revised draft of the regulations on October 9, 2023, including the following material changes:
- Healthcare Entity Definition:
- The initial draft of the regulations explicitly stated that management services organizations (MSOs) were subject to the notice requirement, but the revised draft removes them from the definition of a health care entity . However, the revised draft adds that an organization that acts as an agent of a provider in contracting with payors, negotiating for rates or developing networks would be subject to the notice requirement.
- Healthcare Entity Materiality:
- The initial draft of the regulations required notice if the “transaction involves” healthcare entities meeting certain thresholds. The revised draft changes this language to require notice by a healthcare entity party to the transaction if the entity itself meets the following thresholds:
- Annual revenue of at least $25 million, or owns or controls at least $25 million of California assets
- Annual revenue of at least $10 million, or owns or controls at least $10 million of California assets, and is involved in a transaction with a healthcare entity with annual revenue of at least $25 million, or that owns or controls at least $25 million of California assets
- Located in a designated mental health- or primary care health-professional shortage area
- The initial draft of the regulations required notice if the “transaction involves” healthcare entities meeting certain thresholds. The revised draft changes this language to require notice by a healthcare entity party to the transaction if the entity itself meets the following thresholds:
- Material Change:
- The revised draft of the regulations changes some of the percentage thresholds for circumstances that constitute a material change. For example:
- Previously, a transfer of 20% of a healthcare entity’s assets triggered the notice requirement. The revised draft states that a transfer of 25% of the total California assets of a healthcare entity would trigger the notice requirement.
- Previously, a change of control of 10% of the voting power, operational control or management of a healthcare entity triggered the notice requirement. The revised draft increases this threshold to 25%. However, the revised draft also states that the vesting of supermajority rights, veto rights and similar provisions, even with less than a 25% change of control, would trigger the notice requirement.
- The revised draft clarifies that transactions in the usual and regular course of business of the entity, meaning those that are typical in the day-to-day operations, are not subject to the notice requirement.
- The revised draft adds that a transaction that is part of a series of related transactions, including the acquisition by the acquiring entity of multiple healthcare entities that provide the same or related services, is subject to the notice requirement. Additionally, the proposed transaction and the other related transactions would constitute a single transaction for the purposes of determining whether the transaction meets the revenue thresholds listed above.
- The revised draft of the regulations changes some of the percentage thresholds for circumstances that constitute a material change. For example:
- Expedited Review:
- The revised draft newly establishes a pathway for entities to request expedited review of their materials by providing a detailed explanation of the conditions necessitating expedited review, documentation substantiating the necessity of expedited review, and the date by which the entity requests OHCA to complete its review.
- OHCA retains the right to deny the request for expedited review based on whether the entity has sufficiently demonstrated the need for the transaction to immediately occur. OHCA will consider whether the entity has demonstrated that one or more of the parties to the transaction is in severe financial distress (i.e., a grave risk of immediate business failure and a substantial likelihood that a party will have to file for bankruptcy), and that the transaction is necessary to ensure the provision of critical healthcare services in the area.
KEY TAKEAWAYS
- Transaction Timeline: The notice requirement and CMIR process, as currently drafted, still has the potential to delay the closing of transactions by several months. Healthcare entities entering into material transactions in California should factor this into their overall transaction timeline. Stakeholders should also consider the costs of preparing the notice to OHCA and the additional costs if OHCA decides to conduct a CMIR (for which the costs are reimbursable from the parties to the transaction).
- Expedited Review: The revised draft of the regulations creates an important pathway for entities to request expedited review due to severe financial distress or potential bankruptcy, but OHCA retains the right to deny the expedited review.
- Multiple Submissions: Certain transactions may require more than one entity to submit notice to OHCA. Parties to a transaction that are required to submit notice should carefully coordinate to make sure that their submissions are consistent. If multiple parties to a transaction are required to provide notice, the “clock” for OHCA’s review does not start until all of the parties submit the required notice.
- MSOs: Under the revised draft of the regulations, an MSO is no longer explicitly considered a healthcare entity for the purposes of the transaction notice requirement. However, if an MSO acts as an agent of a healthcare entity in contracting with payors, negotiating for rates, or developing networks, it would be subject to the notice requirement.
- Comment Period: The revised draft of the regulations is subject to change, and stakeholders will have an additional opportunity to influence the development of the final regulations. OHCA is accepting written comments on the revised draft until 5 pm PST on October 17, 2023. After receiving public comments in October and holding an additional board meeting, OHCA plans to submit the final regulations as an emergency rulemaking package in November 2023.

